While previous studies suggested that CD8+ killer T cells were the primary anti-tumor cells, recent research has demonstrated that CD4+ T cells are also capable of secreting granase B to eliminate cancer cells and enhancing the killing function of CD8+ T cells through the secretion of interleukin-2 (IL-2) (24). Here, CD8A is linked to neoplasm.